Beam Therapeutics Cash from Investing (TTM) Trends

Beam Therapeutics Inc (BEAM)

21.62 -1.12 (-4.93%) USD | NASDAQ | Apr 25, 16:00

21.62 0.00 (0.00%) After-Hours: 16:33

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	71.84M
September 30, 2023	87.18M
June 30, 2023	61.24M
March 31, 2023	101.45M
December 31, 2022	-461.34M
September 30, 2022	-652.27M
June 30, 2022	-539.98M
March 31, 2022	-551.86M
December 31, 2021	-294.14M

Date	Value
September 30, 2021	-298.08M
June 30, 2021	-338.96M
March 31, 2021	-302.96M
December 31, 2020	-100.12M
September 30, 2020	-2.137M
June 30, 2020	-23.15M
March 31, 2020	-141.10M
December 31, 2019	-66.66M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-652.27M

Minimum

Sep 2022

101.45M

Maximum

Mar 2023

-203.00M

Average

-141.10M

Median

Mar 2020

Cash from Investing (TTM) Benchmarks